RenovoRx Regains Nasdaq Minimum Bid Price Compliance

What Happened
RenovoRx, Inc. (RNXT) filed an 8-K (Item 8.01) on August 20, 2026, announcing that Nasdaq has confirmed the company is back in compliance with the minimum bid price requirement. Nasdaq notified RenovoRx that the closing bid price for the company's common stock was $1.00 or greater for ten consecutive business days from August 6, 2026 through August 19, 2026, and Nasdaq considers the matter closed.

Key Details

• On December 31, 2025, RenovoRx received notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) after the closing bid had been below $1.00 for 30 consecutive business days.
• Nasdaq confirmed compliance based on the ten consecutive business days of closing bids at $1.00 or more from August 6–19, 2026.
• The company received Nasdaq’s written confirmation on August 20, 2026.
• Ticker: RNXT; common stock par value $0.0001 per share.

Why It Matters
Regaining compliance ends the immediate risk of Nasdaq delisting tied to the sub-$1.00 share-price rule and keeps the company listed, which helps preserve trading liquidity and access to public capital markets. This action addresses a technical listing requirement and does not, by itself, change RenovoRx’s business operations, financial results, or other disclosures.